Business, energy, technology, markets and global industry news from Business News Today

Skip to content

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

SCOUT-HCM

PharmaDeviceNews SCOUT-HCM

Representative image: A cardiologist reviews heart imaging as Cytokinetics’ $CYTK aficamten gains UK approval and NICE backing for approximately 6,600 adults with symptomatic obstructive hypertrophic cardiomyopathy.

Pharma & Biotech

Bristol Myers Squibb Camzyos franchise reaches $1.15bn as pediatric evidence expands

by Pallavi Madhiraju
November 7, 2026
0 Comments

Camzyos maintained lower heart obstruction through 56 weeks in adolescents as Bristol Myers Squibb expands a $1.15 billion HCM franchise.

Read More

Latest news and features

Can Samsung Bioepis challenge Keytruda after its U.S. patent cliff begins in 2028?
Siemens Healthineers carves out diagnostics business as Olyrian after Q4 margin falls to 5.4%
Johnson & Johnson tests Rybrevant beyond NSCLC as OrigAMI-5 Phase 3 trial advances
Immunocore saw 70% of first-line patients alive at two years. Can two T-cell engagers really beat KIMMTRAK alone?
Agenus BOT+BAL shows long-term survival in refractory MSS colorectal cancer
Bristol Myers Squibb Camzyos franchise reaches $1.15bn as pediatric evidence expands
MetaVia’s tiny Phase 1 obesity study just posted 13.5% weight loss and a 68% liver-fat reduction. How much can investors trust yet?
Onkos can put its antibacterial coating on more implants. The FDA claim stops well short of preventing infection
Can Moderna sustain its comeback beyond COVID vaccines and intismeran?
Immunocore reports 70% two-year survival with dual T-cell engager combination in uveal melanoma
What the Zolgensma tumour reports mean for Novartis and AAV gene therapy safety
Can branded GLP-1 medicines replace compounded weight-loss drugs in Hims & Hers growth strategy?

POPULAR NEWS

plated Skin Science’s new BODY Serum brings platelet-derived exosome skincare beyond the face, targeting signs of aging, texture and hydration across the body. Representative image.

Pharma & Biotech

Rion Aesthetics expands plated Skin Science exosome platform with $338 BODY Serum

August 19, 2026

Pharma & Biotech

Omabit raises $2m to connect fragmented clinical evidence, but can AI improve drug development decisions?

October 27, 2026

Medical Devices & Diagnostics

Presage Technologies SmartSpectra cleared for contactless vital signs monitoring

July 8, 2026

Latest business and industry news

Oncolytics Biotech advances cancer immunotherapy strategy as HPV findings boost partnership prospects
Christmas shipping deadlines 2026: USPS vs UPS vs FedEx. When is the last day to send gifts?
HUTCHMED wins second FDA orphan designation, but US approval is still distant
India’s Rs 18,662cr Brahmaputra tunnel faces a critical Rs 11,982cr construction test
Holcim’s Burdett acquisition puts Melbourne’s recycled aggregates market in focus

TAGS

AstraZeneca clinical trials Eli Lilly and Company European Medicines Agency FDA immunotherapy Inc. Johnson & Johnson medical devices non-small cell lung cancer oncology precision oncology U.S. Food and Drug Administration United States Food and Drug Administration US Food and Drug Administration

About PharmaDeviceNews
Disclaimer
Editorial Policy
Privacy Policy
Contact Us

© 2026 PharmaDeviceNews.com. All rights reserved.